DEVICES AND METHODS FOR DETERMINING ANOSMIA AND/OR AGEUSIA
20240324944 ยท 2024-10-03
Inventors
Cpc classification
A23L27/00
HUMAN NECESSITIES
A24F40/30
HUMAN NECESSITIES
International classification
A61B5/00
HUMAN NECESSITIES
Abstract
Systems, devices, and methods for determining anosmia and/or ageusia in a subject. are provided. Devices may include a housing, a composition stored within the housing, and an applicator. The composition may include one or more active ingredients and one or more inactive ingredients, the one or more active ingredients including a flavoring agent that may include salt, sour, sweet, or bitter taste and odor properties. The composition may be configured to remain stable. The housing may include a back pressure mechanism. The applicator may be configured to remove a predetermined amount of the composition from the housing and deliver the predetermined amount of the composition to one or more of a nose and a mouth of the subject.
Claims
1. A sense indicator device, the sense indicator device comprising: a housing; a composition stored within the housing, the composition including: one or more active ingredients including a flavoring agent; and one or more inactive ingredients including a preservative configured to keep the composition stable; and an applicator configured to: remove a predetermined amount of the composition from the housing; and deliver the predetermined amount of the composition to one or more of a nose and a mouth of a subject, wherein the housing includes a back pressure mechanism configured to apply a pressure on the applicator as the applicator is removed from the housing.
2. The sense indicator device of claim 1, wherein the one or more active ingredients is in a concentration less than or equal to 3% and the one or more inactive ingredients is in a concentration greater than or equal to 97%.
3. The sense indicator device of claim 1, wherein the one or more inactive ingredients included in the composition includes one or more of: a skin conditioning agent, a viscosity increasing agent, a viscosity controlling agent, a film former, an occlusive, a masking agent, a solvent, and a sweetener.
4. The sense indicator device of claim 3, wherein the composition includes: the flavoring agent in a concentration of less than or equal to 3%; the skin conditioning agent in a concentration of 80-90%; the viscosity increasing agent in a concentration of 3-10%; and the sweetener in a concentration of less than or equal to 5%.
5. The sense indicator device of claim 1, wherein the back pressure mechanism includes a narrow channel in the housing being diametrically smaller than a width of the applicator.
6. The sense indicator device of claim 1, wherein the applicator includes an angled tip, wherein the predetermined amount of the composition remains on the angled tip of the applicator upon removal of the applicator from the housing.
7. The sense indicator device of claim 1, wherein the applicator includes a sponge tip.
8. The sense indicator device of claim 1, wherein the flavoring agent includes salt, sour, sweet, or bitter taste and odor properties.
9. The sense indicator device of claim 1, wherein the sense indicator device is configured to be administered to the subject to determine one or more of a loss of smell and a loss of taste in the subject.
10. The sense indicator device of claim 9, wherein the determined one or more of the loss of smell or the loss of taste in the subject is a symptom indicative of one or more of a viral infection, a concussion, a brain injury, Parkinson's disease, Alzheimer's disease, epilepsy, dementia, cystic fibrosis, diabetes, multiple sclerosis, breast cancer metastasis, or a nutritional deficiency.
11. The sense indicator device of claim 1, wherein the sense indicator device is configured to stimulate recovery of one or more of a loss of smell and a loss of taste in the subject.
12. A method for determining one or more of a loss of taste and a loss of smell in a subject, the method comprising: removing an applicator of a sense indicator device from a housing of the sense indicator device, wherein a tip of the applicator retains a predetermined amount of a composition by passing through a back pressure mechanism; providing the applicator to one or more of a nose and a mouth of the subject; and determining, using a response of the subject to the providing, one or more of a loss of smell and a loss of taste.
13. The method of claim 12, wherein the method further comprises providing the sense indicator device to the one or more of the nose and the mouth of the subject at predetermined intervals to stimulate recovery of the one or more of the loss of smell or the loss of taste in the subject.
14. The method of claim 12, wherein the method further comprises providing the applicator to the one or more of the nose and the mouth of the subject at predetermined intervals to identify changes in a sense of smell or a sense of taste of the subject over time.
15. The method of claim 14, wherein the method further comprises: recording the response of the subject each time the applicator is provided to the one or more of the nose and the mouth of the subject, and identifying the changes in the sense of smell or the sense of taste of the subject over time based on a change in the response.
16. The method of claim 12, wherein the determined one or more of the loss of smell and the loss of taste is a symptom indicative of one or more of a viral infection, a concussion, a brain injury, Parkinson's disease, Alzheimer's disease, epilepsy, dementia, cystic fibrosis, diabetes, multiple sclerosis, breast cancer metastasis, or a nutritional deficiency.
17. The method of claim 12, wherein the providing the applicator to the mouth of the subject includes applying the predetermined amount of the composition to one or more of a tongue and lips of the subject.
18. The method of claim 12, wherein providing the applicator to the nose of the subject includes holding the applicator below a nostril of the subject.
19. The method of claim 12, wherein the composition includes: one or more active ingredients in a concentration less than or equal to 3%, the one or more active ingredients including a flavoring agent; and one or more inactive ingredients in a concentration greater than or equal to 97%.
20. The method of claim 19, wherein the flavoring agent includes salt, sour, sweet, or bitter taste and odor properties.
21. The method of claim 12, wherein the back pressure mechanism includes a narrow channel in the housing being diametrically smaller than a width of the applicator.
22. The method of claim 12, wherein the tip of the applicator is angled, and wherein the predetermined amount of the composition remains on the angled tip of the applicator upon removal of the applicator from the housing.
23. The method of claim 12, wherein the tip of the applicator includes a sponge material.
24. The method of claim 12, wherein the response of the subject is scored based on one or more positive and/or negative responses.
25. The method of claim 12, wherein the determining includes recording the response of the subject on one or more evaluation sheets.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0009] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate disclosed embodiments and, together with the description, serve to explain the disclosed embodiments. The particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the present disclosure. The description taken with the drawings makes apparent to those skilled in the art how embodiments of the present disclosure may be practiced.
[0010]
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
DETAILED DESCRIPTION
[0021] Embodiments of the present disclosure relate to devices, systems, and methods for determining a loss of taste and/or smell in a subject. More particularly, embodiments of the present disclosure relate to devices, systems, and methods for determining acute, moderate, and chronic anosmia (loss of smell) and/or ageusia (loss of taste) in individuals using the four components of taste and smell (salt, sour, sweet, bitter).
[0022] Embodiments of the present disclosure may be used to identify acute anosmia and/or ageusia, which may be an early indication of various neurological and/or cerebral medical conditions. Additionally, or alternatively, embodiments of the present disclosure may be used to track an individual's sense of smell and taste over time (e.g., in a longitudinal analysis).
[0023] Further, embodiments of the present disclosure may be used to stimulate recovery of a loss of smell and/or taste over time. Of the five most recognized human senses, the only two senses that can heal or improve are the senses of taste and smell. For example, exposure to odor and taste properties consistent with the four components of taste and smell (salt, sour, sweet, bitter), consistent with embodiments of the present disclosure, may agitate glial cells (e.g., as a noxious stimulus), causing the glial cells to proliferate and the local neurons to regain function.
[0024] In some embodiments of the present disclosure, a plurality of ingredients may be combined to form a unique composition, referred to generally as a sense indicator composition, for smell (odor, olfactory) and taste (flavor, gustatory) identification and perception. The use of sense is well known in the biology field as relating to a body perceiving an external stimulus. Although there may be more, the five main human senses relate to vision, hearing, smell, taste, and touch. As used herein, the term sense indicator or sense indicator device may refer to a composition or device that detects a state of two of the five main senses (e.g., taste and smell). Compositions and devices disclosed herein, therefore, may be indicators of a deterioration or improvement in an individual's sense of smell and/or taste when, for example, the composition and/or device is applied/provided to the individual's nose or mouth in different environments and/or at different times/days.
[0025] The sense indicator compositions may comprise taste (flavor) and/or aroma (odor) properties to assess/track sensory perceptions of taste and/or smell. As discussed above, the sense indicator composition 10 may be used as an indicator of a medical condition or disease in which loss of taste and/or smell is a symptom of that medical condition or disease. For example, the medical condition or disease may cause a loss of smell and/or taste. As shown in
[0026] Referring to
[0027] As shown in
[0028] Further, the sense indicator composition may include particular odor and/or taste properties. For example, the sense indicator composition may include an odor and/or taste property of salt, sweet, sour, or bitter. As discussed above, such odor and/or taste properties may correspond to one or more of the four components of taste or smell (salt, sweet, sour, bitter). The particular odor and/or taste properties of the sense indicator composition may be used to determine a loss of smell and/or taste of an individual (e.g., subject) in relation to a particular corner of the four components of taste or smell.
[0029] For example, the sense indicator composition may comprise one or more active ingredients having a taste and/or smell property and one or more non-active ingredients. The active ingredient may include a concentration of an agent (e.g., flavoring agent and/or odor agent) that is sufficient for detection of the odor and/or taste properties of that active ingredient. The active ingredient may include taste (flavor) and/or odor (smell) properties relating to one of the four components of taste and/or smell (salt, sweet, sour, bitter). Thus, an individual's inability to taste and/or smell the flavor and/or odor properties when the sense indicator composition is provided to them may indicate a loss of sense of smell and/or taste. That loss of smell and/or taste may indicate a symptom of a medical condition or disease, such as those discussed further above. The one or more active ingredients also may be of sufficient quality to impart a particular flavor (taste) and/or odor (smell) property. The taste property may involve one or more natural and/or artificial chemicals that provide a particular flavor characteristic/property; the smell property may involve one or more natural and/or artificial chemicals that provide a particular fragrant characteristic/property.
[0030] While the examples discussed below (Tables 1-7) provide for specific types of flavor and smell characteristics or properties (e.g., watermelon, vanilla, mint, coffee), any combination of smells and tastes can be used. For example, the flavor and smell characteristics or properties may be selected to portray one or more of salt, sweet, sour, and bitter characteristics or properties. Further, the flavor and smell characteristics or properties can be tailored to specific regions or local perception of tastes and smells. Individuals living in particular regions or locations may be more familiar with certain tastes and smells compared to individuals living in a different region or location. For example, an individual from one country may be familiar with the taste of a watermelon, while one living in another country may be more familiar with the taste of a papaya.
[0031] The one or more non-active (or inactive) ingredients may be used to preserve the taste (flavor) and smell (odor) characteristics or properties of the one or more active ingredients in the sense indicator composition. For example, the composition may remain stable over an extended period of time (e.g., one year after exposing the composition to ambient atmosphere) due to preservative capabilities imparted by the one or more non-active ingredients. The one or more non-active ingredients may also assist in preventing the taste (flavor) and smell (odor) characteristics or properties of the one or more active ingredients from changing/altering over time. The changing/altering of one or more of the taste (flavor) and smell (odor) characteristics or properties of the one or more active ingredients in the sense indicator composition may result in an unreliability of the individual's (subject's) response to being provided with the sense indicator composition. For example, if the taste and smell characteristics or properties of the sense indicator composition change over time, then an individual's response changing over time cannot be isolated to a change in the individual's sense of smell and/or taste over time, because the taste and smell characteristics or properties of the sense indicator composition are also changing over time. Thus, the ingredients of the sense indicator composition may contribute to improvements over traditional systems and methods by providing the embodiments disclosed herein with the ability to reproduce the same odor and/or taste properties over time/multiple uses.
[0032] Non-limiting examples of sense indicator compositions and their ingredients are provided below.
TABLE-US-00001 TABLE 1 Sense indicator composition (Example 1) Ingredient Concentration Active ingredients: Sense indicator 3% or less Inactive ingredients: Non-sense indicator 97-99.9%
TABLE-US-00002 TABLE 2 Sense indicator composition (Example 2) Ingredient Concentration Flavoring agent 3% or less Skin-conditioning agent: emollient, 97-99.9% viscosity increasing agent - nonaqueous, emollient, skin conditioning, and viscosity controlling; film former; occlusive; masking agent, and solvent; sweetener
TABLE-US-00003 TABLE 3 Sense indicator composition (Example 3) Ingredient Function Concentration Flavoring agent taste and/or odor 3% or less properties hydrogenated skin-conditioning agent - 80-90% polyisobutene controlling emollient, viscosity increasing agent - nonaqueous, emollient, skin conditioning, and viscosity ethylene/propylene/ viscosity increasing agent - 3-10% styrene copolymer nonaqueous butylene/ethylene/styrene film former and film copolymer forming cocos nucifera (coconut) skin-conditioning agent- 5% or less oil miscellaneous; skin- conditioning agent - occlusive, emollient, masking, skin conditioning, and solvent stevioside (steviol sweetener 5% or less glycoside)
TABLE-US-00004 TABLE 4 Sense indicator composition (Example 4) Ingredient Function Concentration Watermelon flavoring taste and/or odor 3% or less agent properties of watermelon hydrogenated skin-conditioning agent - 80-90% polyisobutene controlling emollient, viscosity increasing agent - nonaqueous, emollient, skin conditioning, and viscosity ethylene/propylene/styrene viscosity increasing agent - 3-10% copolymer nonaqueous butylene/ethylene/styrene film former and film copolymer forming cocos nucifera (coconut) skin-conditioning agent- 5% or less oil miscellaneous; skin- conditioning agent - occlusive, emollient, masking, skin conditioning, and solvent stevioside (steviol sweetener 5% or less glycoside)
TABLE-US-00005 TABLE 5 Sense indicator composition (Example 5) Ingredient Function Concentration Vanilla flavoring agent taste and/or odor 3% or less properties of vanilla hydrogenated skin-conditioning agent - 80-90% polyisobutene controlling emollient, viscosity increasing agent - nonaqueous, emollient, skin conditioning, and viscosity ethylene/propylene/ viscosity increasing agent - 3-10% styrene copolymer nonaqueous butylene/ethylene/styrene film former and film copolymer forming cocos nucifera (coconut) oi skin-conditioning agent- 5% or less miscellaneous; skin- conditioning agent - occlusive, emollient, masking, skin conditioning, and solvent stevioside (steviol sweetener 5% or less glycoside)
TABLE-US-00006 TABLE 6 Sense indicator composition (Example 6) Ingredient Function Concentration Mint flavoring agent taste and/or odor 3% or less properties of mint hydrogenated skin-conditioning agent - 80-90% polyisobutene controlling emollient, viscosity increasing agent - nonaqueous, emollient, skin conditioning, and viscosity ethylene/propylene/ viscosity increasing agent - 3-10% styrene copolymer nonaqueous butylene/ethylene/styrene film former and film copolymer forming cocos nucifera (coconut) skin-conditioning agent- 5% or less oil miscellaneous; skin- conditioning agent - occlusive, emollient, masking, skin conditioning, and solvent stevioside (steviol sweetener 5% or less glycoside)
TABLE-US-00007 TABLE 7 Sense indicator composition (Example 7) Ingredient Function Concentration Coffee flavoring agent taste and/or odor 3% or less properties of coffee hydrogenated skin-conditioning agent - 80-90% polyisobutene controlling emollient, viscosity increasing agent - nonaqueous, emollient, skin conditioning, and viscosity ethylene/propylene/styrene viscosity increasing agent - 3-10% copolymer nonaqueous butylene/ethylene/styrene film former and film copolymer forming cocos nucifera (coconut) skin-conditioning agent - 5% or less oil miscellaneous; skin conditioning agent - occlusive, emollient, masking, skin conditioning, and solvent stevioside (steviol sweetener 5% or less glycoside)
[0033] In some embodiments, the sense indicator composition may be single use. In other embodiments, the sense indicator composition may be multiple use. For example, the sense indicator composition, consistent with embodiments disclosed herein, may be used, when administered periodically or over time, to identify a baseline of an individual's taste and smell. As such, periodic assessments may allow for tracking taste and smell changes, both taste and/or smell deteriorations or taste and/or smell improvements, both physiologically and neurologically over time when, for example, being compared to initial baseline scores.
[0034]
[0035]
[0036] As shown in
[0037] Additionally or alternatively, as shown in
[0038] It is contemplated that the identification of what individual 20 is smelling or tasting can include different terms that apply to each corner of the four components of taste and smell. For example, a response indicative of salt may involve any one or more of the following descriptors: watermelon, fresh, green, juicy, fruity, salt. A response indicative of sweet may involve any one or more of the following descriptors: vanilla, warm, woodsy, comforting, sugar, sweet. A response indicative of sour may involve any one or more of the following descriptors: mint, herbal, cool, refreshing, tart, sour. A response indicative of bitter may involve any one or more of the following descriptors: coffee, acidic, aromatic, nutty, awakening, unsweetened, bitter.
[0039]
[0040] The detection and identification of the smell or taste may be recorded by positive and negative responses. A positive response (1) may include a detection of a smell or taste property, and a negative response (0) may include a lack of detection of a smell or taste property. For example, a positive response may pertain to an individual detecting that they taste or smell something, and a negative response may pertain to the individual failing to smell or taste anything. Further, a positive response (1) may include a correct identification of the smell or taste property, and a negative response (0) may include an incorrect identification of the smell or taste property. For example, a positive response may pertain to an individual correctly identifying what the designated taste or smell property of the particular sense indicator composition is (e.g., salt, sweet, sour, bitter), and a negative response may pertain to the individual incorrectly identifying what the designated taste or smell property of the particular sense indicator composition is.
[0041] The kit may be provided to the individual in different environments (e.g., on the athletic field, in the medical tent, in the locker room, in a combat environment) to both track the progression of the individual's sense of taste and/or smell over time, and/or to evaluate the individual's sense of taste and/or smell in different environments (because the ambient environment may impact the detection and identification of a particular smell/taste).
[0042]
[0043]
[0044] This objective and reliable evaluation of an individual's sense of smell and/or taste over time may provide an early prediction or diagnosis of various cognitive or sensory disorders (e.g., Parkinson's disease, Alzheimer's disease) where early detection may provide a window of opportunity (e.g., 10-15 years) prior to a confirmed identification of its presence (e.g., a presence of amyloid plaques in the brain) as detected by other modalities (e.g., MRI, CT). This window of opportunity may provide a time frame for development and administration of preventative pharmacological therapeutics and other modes of treatment that may delay and/or prevent further cognitive deterioration. Periodic, continued use by individuals (subjects) who exhibit a loss or diminished ability to accurately detect and/or identify one or more of these core tastes or odorants (e.g., one of the four discussed above as the four components of taste and/or smell) can, in some embodiments, provide noxious stimulation to assist in regaining (or recovering) both perception and identification of these taste and/or odor properties. Further, embodiments of the present disclosure may be used to identify particular smell and/or taste properties that an individual is unable to detect and/or identify, which may be indicative of a deficiency of a particular nutrient (or malnutrition). Thus, embodiments of the present disclosure may be used in tandem with, for example, chemotherapy as an indicator of particular nutritional (e.g., vitamin, mineral) deficiencies that may be caused by, for example, heavy metal chemotherapy drugs. Additionally, or alternatively, some embodiments of the present disclosure may be used to evaluate and develop drug treatments for various neurological disorders and diseases.
[0045] Early use of the sense indicator devices, sense indicator compositions, and/or the scoring systems with evaluation sheets disclosed herein can objectively, and without bias, document and score the onset of various neurological and cerebral medical conditions. Subsequent periodic use of the sense indicator devices, sense indicator compositions, and/or the scoring systems with evaluation sheets disclosed herein can provide documentation of improvements or deterioration of cognition and/or identification of smell and/or taste properties corresponding to the four components of smell and/or taste. In some embodiments, devices, systems, and methods disclosed herein may also be in medical cohort research studies. In contrast to existing devices, systems, and methods, which examine diagnostic biomarkers that do not change over time, olfactory and gustatory functions can change with improvements in clinical condition and have wide-ranging promise as an early diagnostic biomarker as well as an indicator of clinical improvement.
[0046] The foregoing description has been presented for purposes of illustration. It is not exhaustive and is not limited to precise forms or embodiments disclosed. Modifications and adaptations of the embodiments will be apparent from consideration of the specification and practice of the disclosed embodiments. While certain components have been described as being coupled to one another, such components may be integrated with one another or distributed in any suitable fashion.
[0047] Moreover, while illustrative embodiments have been described herein, the scope includes any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations and/or alterations based on the present disclosure. The elements in the claims are to be interpreted broadly based on the language employed in the claims and not limited to examples described in the present specification or during the prosecution of the application, which examples are to be construed as nonexclusive. Further, the steps of the disclosed methods can be modified in any manner, including reordering steps and/or inserting or deleting steps.
[0048] The features and advantages of the disclosure are apparent from the detailed specification, and thus, it is intended that the appended claims cover all systems and methods falling within the true spirit and scope of the disclosure. As used herein, the indefinite articles a and an mean one or more. Similarly, the use of a plural term does not necessarily denote a plurality unless it is unambiguous in the given context. Words such as and or or mean and/or unless specifically directed otherwise. Further, since numerous modifications and variations will readily occur from studying the present disclosure, it is not desired to limit the disclosure to the exact construction and operation illustrated and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the disclosure.
[0049] Throughout this application, various embodiments of the present disclosure may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the present disclosure. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numeric values within that range. For example, description of a range such as from 1 to 6 should be considered to include subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, and so forth, as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.
[0050] Other embodiments will be apparent from consideration of the specification and practice of the embodiments disclosed herein. It is intended that the specification and examples be considered as example only, with a true scope and spirit of the disclosed embodiments being indicated by the following claims.